Table 4.
Kinetic modeling data of norfloxacin nanoparticulate formulations (N1-N9
| Formulation code | Burst release phase | Sustained release phase | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Zero order | First order | Higuchi | Zero order | First order | Higuchi | Peppas | |||
| R2 | n | ||||||||
| N1 | 0.911 | 0.638 | 0.994 | 0.981 | 0.981 | 0.965 | 0.984 | 0.589 | |
| N2 | 0.972 | 0.694 | 0.955 | 0.981 | 0.988 | 0.96 | 0.976 | 0.495 | |
| N3 | 0.939 | 0.674 | 0.994 | 0.983 | 0.948 | 0.978 | 0.994 | 0.565 | |
| N4 | 0.906 | 0.636 | 0.994 | 0.948 | 0.902 | 0.993 | 0.998 | 0.566 | |
| N5 | 0.883 | 0.632 | 0.986 | 0.965 | 0.945 | 0.968 | 0.988 | 0.550 | |
| N6 | 0.896 | 0.639 | 0.997 | 0.965 | 0.912 | 0.972 | 0.978 | 0.507 | |
| N7 | 0.934 | 0.65 | 0.989 | 0.955 | 0.894 | 0.980 | 0.982 | 0.511 | |
| N8 | 0.933 | 0.653 | 0.982 | 0.973 | 0.932 | 0.986 | 0.997 | 0.502 | |
| N9 | 0.949 | 0.675 | 0.977 | 0.982 | 0.947 | 0.974 | 0.991 | 0.521 | |